ArticleBioengineering (Basel, Switzerland)2023

Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts.

Laxmi Dhungel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.